The American Society for Microbiology honors Frank Leo van de Veerdonk

June 20, 2013

Washington, D.C. - June 18, 2013 - Frank Leo van de Veerdonk, M.D., Ph.D., Nijmegen Medical Centre Radboud University (RUNMC) and Nijmegen Institute for Infection, Inflammation and Immunity (N4i), has received a 2013 ICAAC Young Investigator Award for his work in the field of fungal immunology. Charles Dinarello, University of Colorado, says, "I see Frank as one of the new generation of innovative thinkers in the field of cytokine biology, particularly as it applies to infection."

Van de Veerdonk earned his medical degree in 2001 from the Vrije Universiteit in Amsterdam. He started as a resident in Internal Medicine at Jeroen Bosch Hospital in s' Hertogenbosch under the supervision of Paetrick Netten. In 2006, he continued his training in Internal Medicine at Radboud University in Nijmegen where he was supervised by Jos van der Meer. He began his Ph.D. in 2007, and under the supervision of Mihai Netea, he studied pattern recognition receptors and pathogen associated molecular patterns of Candida albicans and Candida-specific innate and adaptive immune responses. During this time new insights in Th17 biology were discovered and van de Veerdonk found that mutations in STAT1 that lead to gain of function are responsible for autosomal dominant chronic mucocutaneous candidiasis. Mihai Netea, Radboud University Nijmegen, considers this discovery, "a major breakthrough in the diagnosis of immunodeficiencies with fungal infections."

While completing his Ph.D., he worked at St. Jude's Children Research Hospital in the laboratory of Thirumala Kanneganti, where he studied the role of the inflammasome in invasive candidiasis. After receiving a Niels Stensen Stipend in 2010, he went to the University of Colorado to study the role of the new interleukin-1 (IL 1) family members IL-36, IL-37 and IL-38 under the supervision of Charles Dinarello. Dinarello considers van de Veerdonk "a gifted physician/scientist who always has his eye focused on what we can learn from patients." While van de Veerdonk was at the University of Colorado, he discovered that IL-38 binds to the IL-36R and acts similar to IL-36Ra on immune cells. After returning to Nijmegen he finished his Ph.D. and graduated cum laude from Radboud University.

In 2011 van de Veerdonk completed his fellowship in infectious diseases. Then in 2012 he became a faculty member at Radboud University Nijmegen Medical Centre where he works as an internist-infectious diseases specialist. He received a grant from the Nijmegen Centre for Molecular Life Sciences (NCMLS) and a Veni grant from Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) to build his own research group in the laboratory of Mihai Netea and Leo Joosten. Van de Veerdonk is focusing his research on the host defense against Aspergillus and the functional biology of the new IL 1 family members IL-36, IL-37 and IL-38.
-end-
The ICAAC Young Investigator Award will be presented during ASM's 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 10-13, 2013 in Denver, Colorado. ASM is the world's oldest and largest life science organization and has more than 40,000 members worldwide. ASM's mission is to advance the microbiological sciences and promote the use of scientific knowledge for improved health, economic, and environmental well-being.

American Society for Microbiology

Related Internal Medicine Articles from Brightsurf:

COVID-19 news from Annals of Internal Medicine
In this Ideas and Opinions piece from the University of California, San Francisco and San Francisco Veterans Affairs Medical Center, the authors discuss the findings of early studies that addressed the use of chest computed tomography for the detection of COVID-19.

New COVID-19 content from Annals of Internal Medicine
Below please find links to new coronavirus-related content published today in Annals of Internal Medicine.

Changes in internal medicine subspecialty choices of women, men
This study used enrollment data to examine changes in the internal medicine subspecialty choices of women and men from 1991 to 2016.

Do internal medicine residents feel bullied during training?
This research letter uses survey data to report on perceived bullying by internal medicine residents during training.

Annals publishes annual updates in internal medicine
Annals of Internal Medicine, the flagship journal of the American College of Physicians (ACP), has published summaries of the most important medical studies published in 2016 in the fields of general internal medicine, cardiology, hematology, endocrinology, gastroenterology and hepatology, rheumatology, and perioperative, pulmonary, and geriatric medicine.

News from Annals of Internal Medicine April 7, 2015
In the next issue of Annals of Internal Medicine are: Weight Watchers and Jenny Craig come out on top among commercial weight loss programs; Physical therapy as effective as surgery for lumber spinal stenosis; and Leading internists call for more thoughtful use of CPR.

News from Annals of Internal Medicine March 31, 2015
Articles include: USPSTF reviews evidence to update recommendations on iron supplementation and deficiency screening in pregnant women; New hep C treatments are cost-effective for some patients, yet may exceed insurers' willingness to pay.

News from Annals of Internal Medicine March 24, 2015
The US Preventive Services Task Force concludes that the current evidence is insufficient to recommend for or against screening for thyroid dysfunction in nonpregnant, asymptomatic adults.

News from Annals of Internal Medicine Feb. 10, 2015
Using Lung Imaging Reporting and Data System (Lung-RADS) criteria developed by the American College of Radiology to interpret low-dose CT lung screening results may reduce false positives compared to the National Lung Screening Trial, but the trade-off is reduced sensitivity, according to an article published in Annals of Internal Medicine.

News from Dec. 23, 2014, Annals of Internal Medicine
The Dec. 23, 2014, issue of Annals of Internal Medicine includes 'Blood pressure drugs likely to prevent stroke and death in patients with mild hypertension' and 'Task force reviews evidence to update blood pressure screening recommendations.'

Read More: Internal Medicine News and Internal Medicine Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.